AI trains doctors to better detect stomach cancer risk

NCT ID NCT07208864

Not yet recruiting Diagnosis Sponsor: Qilu Hospital of Shandong University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence (AI) system can help doctors more accurately score a stomach condition called gastric intestinal metaplasia, which can lead to cancer. Eight endoscopists will review videos of stomach exams, some with AI help and some without, to see if the AI improves their scoring. The goal is to make diagnosis more consistent and reliable, especially for less experienced doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted EGGIM scoring system
What this could lead to: If it works, this could lead to more accurate and consistent diagnosis of a precancerous stomach condition, helping doctors identify high-risk patients earlier.
What could go wrong: This is a very small, early study with only 8 endoscopists, so results may not apply broadly. The AI is a training tool, not a treatment, and its real-world impact remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC INTESTINAL METAPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric intestinal metaplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC INTESTINAL METAPLASIA

Contacts and locations

Locations

Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.